Editorial

» opinion, cancer and science publishing

Most Recent

image: Transparency Now

Transparency Now

By | May 1, 2016

Science is messy. So lay it out, warts and all.

1 Comment

image: Shooting for the Moon

Shooting for the Moon

By | April 1, 2016

Science is messy. So lay it out, warts and all.

4 Comments

image: To Each His Own

To Each His Own

By | April 1, 2015

Science is messy. So lay it out, warts and all.

0 Comments

image: Search and Destroy

Search and Destroy

By | April 1, 2014

Science is messy. So lay it out, warts and all.

0 Comments

image: Making Cancer More Transparent

Making Cancer More Transparent

By | April 1, 2013

Science is messy. So lay it out, warts and all.

3 Comments

image: Survival of the Fittest (to print)

Survival of the Fittest (to print)

By | August 1, 2012

Science is messy. So lay it out, warts and all.

5 Comments

image: Avant-Garde Science

Avant-Garde Science

By | June 1, 2012

Science is messy. So lay it out, warts and all.

0 Comments

image: Agents Provocateurs

Agents Provocateurs

By | April 1, 2012

Science is messy. So lay it out, warts and all.

3 Comments

A Truly Happy Return

By | December 1, 2011

Science is messy. So lay it out, warts and all.

12 Comments

. . . And Many Happy Returns

By | October 1, 2011

Science is messy. So lay it out, warts and all.

0 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech